Drug trial shows promise for improving alertness in shift workers

For millions of people working nights, life is a constant battle against their natural circadian rhythm.

Shift Work Sleep Disorder (SWSD) impacts up to 40% of these workers, causing extreme daytime sleepiness and insomnia.

While stimulants like caffeine or prescription modafinil are standard, scientists are now testing new, targeted drugs designed to promote alertness more safely by avoiding traditional pathways that risk dependency.

Managing SWSD effectively requires a holistic approach, including strategic napping, controlled light therapy, and rigorous sleep hygiene.

As research moves toward personalized, chronotype-based medicine, the hope is to reduce both the cognitive decline and the safety risks associated with non-traditional schedules.